Posted by
TMS for Perinatal Depression

TMS for Perinatal Depression

By Paul Croarkin, DO, Research Committee Co-chair and Philip Janicak, MD, Research Committee Member Introduction Perinatal depressions are serious, debilitating conditions which are often under-recognized; and, even when properly diagnosed, often sub-optimally treated.  Notably, they can contribute to problematic maternal behaviors such as substance use, poor self-care, non-adherence to prenatal care, and a heightened risk for […]

Posted by
Ketamine Found Effective for Patients With Anxious Treatment-Resistant Depression

Ketamine Found Effective for Patients With Anxious Treatment-Resistant Depression

Patients with anxious depression—major depressive disorder (MDD) with high levels of anxiety—are known to have a poorer response to commonly used antidepressants than those with MDD. A small study published in Depression & Anxiety now suggests intravenous (IV) ketamine may be able to reduce symptoms in patients with anxious depression. The study found patients with and without anxious depression […]

Posted by
Being Bullied May Alter the Teen Brain

Being Bullied May Alter the Teen Brain

By Alan Mozes HealthDay Reporter THURSDAY, Dec. 27, 2018 (HealthDay News) — Teens who are often bullied may be left with shrinkage in key parts of their brain, increasing their risk for mental illness, European researchers report. They said such shrinkage eventually appears to create a growing sense of anxiety, even after taking into account […]

Posted by
TBS: My Experience

TBS: My Experience

Reason for Treatment: depression and anxiety for 5-6 years. Started with panic attacks and anxiety. outside stressors developed depression that escalated over time. panic attacks under control with proper medication. depression hit it’s worst state in the middle of 2018. I was ready to quit on everything. I was not suicidal or interested in losing […]

Posted by

WITHOUT REMISSION, THE BURDEN OF MDD GROWS

For 50 years, pharmacological treatment approaches in MDD have focused on targeting monoamine receptors in the hopes of reducing symptoms. While conventional therapies have helped many, the STAR*D trial* revealed that as many as a third of patients may not achieve remission despite treatment with traditional antidepressants.¹,² Dr Rakesh Jain, clinical professor of psychiatry at […]

Posted by
Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings

Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings

Key Points Question  What are the trends across adulterated dietary supplements associated with a warning released by the US Food and Drug Administration from 2007 through 2016? Findings  In this quality improvement study, analysis of the US Food and Drug Administration warnings from 2007 through 2016 showed that unapproved pharmaceutical ingredients were identified in 776 dietary supplements, […]

Posted by
Precision Medicine:The Future is Coming Fast

Precision Medicine:The Future is Coming Fast

Promise of Precision Medicine in Psychiatry Nears Reality BARCELONA, Spain — Innovative approaches and widespread data sharing are essential in psychiatry to improve patient care and deliver on the long-held promise of precision medicine, a leading European expert says. In a plenary lecture delivered here at the 31st European College of Neuropsychopharmacology (ECNP) Congress, Marion […]

Posted by

The APA Brings Genetic Testing Under Fire, Genomind and Genesight Respond

On April 25th 2018 the American Psychiatric Association published the following criticism of genomic testing emphasizing their skepticism towards psychiatrists who are using genetic testing to make informed decisions about diagnosis and treatment. An abstract of their statement reads:       Evidence Does Not Support Commercial Rush Of DNA Tests Designed To Inform Decisions […]

Posted by
Is the Ketamine Boom Getting out of Hand? A Response.

Is the Ketamine Boom Getting out of Hand? A Response.

On September 26 2018 Scientific American published an article calling out some of the business practices being used by ketamine treatment providers across the country. The article summarized legitimate concerns about the business side of the ketamine while reiterating the promise ketamine shows as a breakthrough treatment for difficult to treat cases of depression. “This […]